The changes in ALS and AD are not found universally in all neurodegenerative diseases, however, since neither the expression of MCT1 or MCT2, nor the content of lactate, is altered in the substantia nigra and striatum in an experimental mouse model of Parkinson’s disease (Puchades et al., 2013). The gene discussed is SLC16A1; the disease is Alzheimer disease.